High-throughput human metabolism and toxicity analysis.

Area of Science:

• Pharmacology
• Drug Discovery
• Toxicology

Background:

• Late identification of poor drug candidate safety profiles increases drug discovery costs and reduces success rates.
• Current drug development faces challenges in accurately predicting human in vivo responses and toxicology from early screening.
• Existing high-throughput screening methods often fail to translate effectively to predicting clinical outcomes.

Purpose of the Study:

• To highlight the need for advanced tools for early assessment of drug candidate toxicity and human metabolism.
• To discuss the challenges in developing predictive screening platforms for drug toxicology.
• To review recent successes in improving early-stage drug safety assessment.

Main Methods:

• Review of existing high-throughput screening techniques in drug discovery.
• Analysis of challenges in translating preclinical screening to in vivo human response prediction.
• Examination of recent advancements in predictive toxicology platforms.

Main Results:

• Drug candidate safety issues are frequently discovered late, impacting cost and efficiency.
• Developing accurate in vivo predictive models from in vitro screening remains a significant hurdle.
• Recent progress indicates potential for improved early-stage safety assessment tools.

Conclusions:

• Accelerating the assessment of drug toxicity and metabolism is crucial for efficient drug discovery.
• New tools are essential to overcome limitations of current screening methods in predicting human response.
• Emerging technologies show promise for wider adoption in the pharmaceutical industry for better drug safety evaluation.